You are here: Industry Insights > COVID-19

News List

Global trial to evaluate Kevzara® (sarilumab) as COVID-19 therapy initiated europeanpharmaceuticalreview
March 31, 2020
A Phase II/III trial to study Kevzara (sarilumab) as a method to reduce the inflammatory response in the lungs of COVID-19 patients has begun outside of the US.
Big pharma’s in-house manufacturing impacted by COVID-19 outbreak in China europeanpharmaceuticalreview
March 31, 2020
According to an outlet, the in-house manufacturing of biopharma products has been threatened by the COVID-19 outbreak, especially in China.
Nafamostat is expected to prevent the transmission of new coronavirus infection (COVID-19) worldpharmanews
March 31, 2020
Nafamostat mesylate (brand name: Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19). The University of Tokyo anno
EMA advises continued use of hypertension drugs during COVID-19 pandemic europeanpharmaceuticalreview
March 31, 2020
The EMA has said that patients should continue to use angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), despite reports that these worsen COVID-19 infections.
Moderna to pause certain clinical development activities amid Covid-19 pharmaceutical-technology
March 31, 2020
Biotechnology firm Moderna has provided an update on the impact of the Covid-19 pandemic on its clinical development activities and business operations.
Researcher in India designs potential Covid-19 vaccine candidates pharmaceutical-technology
March 31, 2020
A researcher at University of Hyderabad (UoH) in India has designed potential Covid-19 vaccine candidates referred to as T-cell epitopes.
Altimmune and UAB to develop intranasal coronavirus vaccine pharmaceutical-technology
March 31, 2020
Biopharmaceutical firm Altimmune has partnered with the University of Alabama at Birmingham (UAB) to develop a Covid-19 vaccine for intranasal administration.
J&J partners with BARDA to commit $1bn to Covid-19 vaccine development pharmaceutical-technology
March 31, 2020
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and Human Service (HSS)’s Biomedical Advanced Research and Development Authority (BARDA).
GoI allows pharmacists to deliver medicines at doorsteps expresspharma
March 31, 2020
Licensee can sell/deliver such drugs maintaining the receipt of prescription physically or through e-mail.
Government asks MoEFCC to expedite clearance of API/intermediates expresspharma
March 31, 2020
The Union Government has asked the Ministry of Environment, Forest and Climate Change (MoEFCC) to expedite the prior environmental clearance to projects or activities in respect of APIs/bulk drugs and intermediates.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page